
Daily Derm Times: May 26, 2025
Key Takeaways
- Atopic dermatitis and alopecia areata have profound mental health and socioeconomic impacts, highlighting the need for improved support and awareness.
- Sarah Allen, MD, launches a virtual Esthetician Program, enhancing access to personalized skincare consultations for patients.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our
AD and AA Severely Impact Mental Health and Daily Life
Explore the significant mental health and socioeconomic impacts of atopic dermatitis and alopecia areata, revealing urgent needs for better support and awareness.
Q&A: Sarah Allen, MD, Unveils Skin Clique’s Virtual Esthetician Program
Sarah Allen, MD's Skin Clique has launched a virtual Esthetician Program, providing personalized skincare consultations and bridging access to expert guidance for all patients.
Depression Risks in Patients With Vitiligo Vary Significantly by Race and Ethnicity
New research reveals significant racial disparities in depression risk among vitiligo patients, highlighting the need for culturally sensitive mental health support.
Temtokibart Demonstrates Efficacy in Adults With Moderate to Severe Atopic Dermatitis
LEO Pharma reveals promising phase 2b trial results for temtokibart, a treatment targeting moderate to severe atopic dermatitis effectively.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















